UroToday.com ✓

@urotoday · Reno, NV · joined 19 Feb 2009

Largest global online community of #urological medical professionals & patients. #bladdercancer #menshealth #prostatecancer #kidneycancer #Urology

31 264Followers

5 984Following

126 094Posts total

1.9KViews on collected posts

Derniers posts

UroToday.com ✓@urotoday16 Sep

PSMA PET interpretation in biochemical recurrence after #ProstateCancer treatment. Steve Cho, MD joins @tranpt21 highlighting that detection is most reliable at PSA 0.2–0.5 ng/mL—below this, a negative scan does not exclude disease. ✅ Small PSMA-avid lymph nodes can be highly htt

44 views · 0 likes · 0 reposts · 0 replies Open on X →

UroToday.com ✓@urotoday16 Sep

CAPItello-281 and the PTEN-deficient subset of metastatic hormone-sensitive #ProstateCancer. @CaPsurvivorship @danafarber joins @neerajaiims @huntsmancancer to discuss CAPItello-281. The trial supported the approval of capivasertib + abiraterone in PTEN-deficient #mHSPC, a https:

128 views · 0 likes · 0 reposts · 0 replies Open on X →

UroToday.com ✓@urotoday16 Sep

Radiopharmaceuticals in #ProstateCancer: Payloads, Carriers, Targets, and Combinations. Michael Morris, MD @MSKCancerCenter & @DrRanaMcKay @UCSanDiego join @DrPhilKantoff @ConvergentRx to discuss isotope and carrier selection, combination strategies, and emerging targets in https

138 views · 1 likes · 0 reposts · 0 replies Open on X →

UroToday.com ✓@urotoday16 Sep

Patient-reported outcomes with EV-pembrolizumab vs cystectomy alone in #MIBC. Peter O'Donnell, MD @UChicagoMed joins @ERPlimackMD @FoxChaseCancer sharing a PRO analysis from KEYNOTE-905 comparing EV + pembrolizumab against cystectomy alone in muscle-invasive #BladderCancer. The h

280 views · 3 likes · 0 reposts · 0 replies Open on X →

UroToday.com ✓@urotoday16 Sep

Multidisciplinary teams to address quality and documentation of bladder tumor resection. @pjhensley11 @UKYMedicine sits down with @UroDocAsh @UTMDAnderson to discuss the IBCG 2026 focus on TURBT quality, marking the first time the retreat has centered on a procedure rather than a

292 views · 0 likes · 0 reposts · 0 replies Open on X →

UroToday.com ✓@urotoday31 May

First interim analysis of SWOG S1823/GCC.1: Operating characteristics of circulating microRNA 371a-3p (miR371) in predicting active germ cell malignancy (aGCM) in patients with early-stage #TesticularCancer. Presentation by @LuciaNappi4 @VanProstateCtr. #ASCO26 written coverage h

1.1K views · 9 likes · 8 reposts · 0 replies Open on X →

Face aux comptes de taille comparable

5 posts des 90 derniers jours, à côté de la tranche de 10K–100K abonnés. touche moins de monde que les comptes de taille comparable.

Vues médianes138ce compte914médiane pour 10K–100K

Portée, %0.44%ce compte3.38%médiane pour 10K–100K

Engagement, %0.00%ce compte1.53%médiane pour 10K–100K

Indicateur	Ce compte	Médiane pour 10K–100K	Rapport
Vues médianes par post	138	914	0.15×
Portée (vues ÷ abonnés)	0.44%	3.38%	0.13×
Taux d'engagement	0.00%	1.53%	0.00×

Autres comptes de cette tranche → Comparer avec un autre compte → Comment ces repères sont établis →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

1.1K31 May

29216 Sep

280

138

128

Last 6 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

1.71%31 May

0.00%16 Sep

1.07%

0.72%

0.00%

Reactions — likes, reposts, replies and quotes — divided by views. Median for 10K–100K accounts is 1.53%.

What the audience does

Likes59.1%13 in total

Reposts36.4%8 in total

Quotes4.5%1 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.

Derniers posts

Face aux comptes de taille comparable

Growth & engagement

Views per post

Engagement rate per post

What the audience does

Comptes similaires